期刊文献+

胚胎移植后输卵管妊娠的高危因素分析 被引量:9

Analyze the Ectopic Pregnancy after in Vitro Fertilization and Embryo Transfer
下载PDF
导出
摘要 目的:探讨不孕症患者辅助生殖技术胚胎移植后输卵管妊娠高危因素及诊断。方法:对不孕症患者辅助生殖技术后输卵管妊娠者和同时期宫内单胎妊娠患者(对照组)的临床资料进行回顾性分析。结果:输卵管妊娠组既往存在输卵管病变者明显高于宫内单胎妊娠组(P<0.05);采用卵母细胞单精子注射(ICSI)发生输卵管妊娠多于体外受精(IVF)治疗者(P<0.05);冷冻胚胎移植输卵管妊娠发生率较采用新鲜胚胎移植者更高(P<0.05);宫内单胎组胚胎移植后14天血β-HCG浓度要明显高于输卵管妊娠组(P<0.01)。输卵管妊娠组β-HCG倍增时间明显长于宫内单胎组(P<0.01)。结论:不孕症患者辅助生殖技术(ART)胚胎移植后输卵管妊娠的发生率高与输卵管病变有关。胚胎移植后测定β-HCG,结合经阴道超声检查有助于输卵管妊娠的早期诊断。 Objective: To analyze risk factors of ectopic pregnancy (EP) after in vitro fertilization - embryo transfer ( IVF - ET), and its diagnosis. Methods:Tha clinical data of EP group and control group (intrauterine singleton pregnancy) were retrospectively analyzed. Results:Tha EP group had higher fallopian tube diseases history than control group,76% and 43% respectively; EP patients treated by ICSI were more than those by IVF( X^2 = 4.11, P〈 0.05) ; EP patients after frozen embryo transfer were more than those after fresh embryo transfer( X^2 = 4: 57, P 〈 0.05) ; EP patients' average serurnβ-HCG level at Day 14 after ET was obviously lower than those from the normal pregnancy (P〈 0.01 ), and the doubling time (3.6 vs 1.7 days) was significant longer ( P〈 0.01 ) .Conclusions:Tubal pathology is associated with increased risk of EP. β-HCG assay assisted with Transvaginal ultrasound inspection are helpful to the early diagnosis of EP.
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2008年第1期33-35,共3页 Journal of Practical Obstetrics and Gynecology
基金 国家自然科学基金(30670777) 国家973项目(2006CB944004)
关键词 胚胎移植 输卵管妊娠 不孕症 In vitro fertilization embryo transfer Tubal pregnancy Infertility
  • 相关文献

参考文献9

  • 1Bonyer J,Coste J,Shojaei T,et al.Risk factors for ectopic pregnancy:a conrprehensive analysis based on a large case-control,population-based study in France[J].Am J Epidemiol,2003,157(3):185-194.
  • 2盛燕,陈子江,高芹,唐蓉,石玉华,孙梅.促性腺激素释放激素用量对体外受精-胚胎移植影响的探讨[J].山东大学学报(医学版),2003,41(6):664-666. 被引量:4
  • 3Herve Fernandez,Amelie Gervaise.Ectopie pregnancies after infertility treatment:modem.diagnosis and therapeutic strategy[J].Human Reproduction Update,2004,10(6);503-513.
  • 4Klipstein S,Oskowitz SP.Bilsteral eetepie pregnancy after transfer of two embryos[J].Fertil Steril,2000,74(5):887-888.
  • 5Coroleu B,Barri PN,Carreras 0.3he intluel'ice of the depth of embryo replacementin to the uterine cavity on implantation rates after IVF:a Controlled,ultrasound-guided stuay[J].Hum Repmd,2002,17(2):341-346.
  • 6Pope CS,Cook EK,Amy M,et al.Influence of embryo transfer depth on in vitro fertilization and embryo transfer outcomes[J].Fertil Stelil,2004,81(1):51-58.
  • 7Jun SH,Milki AA.Assisted hatching is associated with a hishez ectepic pregnancy rate[J].Fertil Steril,2004,81(3):1701-1703.
  • 8Milki AA,Jun SH.Ectopic pregnancy rates with day 3 versus day 5 embryo transfer:a retrospective analysis[J].BMC Pregnancy Childbirth,2003,3(1):7.
  • 9Janos Urbancsek,Erik Hanmmn,Peter Fedorcsak,et al.Scnnn human chofionic ganadotropin measurements may predict pregnancy outcome and multiple gestation after in vitro fertilization[J].Ferti&Steri,2002,78(3):540-542.

二级参考文献6

  • 1Erickson LD,Ory SJ. GnRH analogues in the treatment of endometriosis [J]. Obstet Gynecol Clin North Am,1989,16:123
  • 2Selmo Geb er, Liana Sales. Comparison between a Single Dose of Goserelin (Depot) and Multiple Daily DosIVF Treatment: A Clinical Endocrinological Study of the Ovarian Response [J]. Journal of Assisted Reproduction and Genetic, 2002,19(7):313
  • 3Abdalla HI, Ahuja KK, Leonard T, et al. Comparative trial of luteinizing hormonereleasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program [J]. Fertil Steril, 1990,53:473
  • 4Hughes EG, Fedorkow DM, Daya S, et al. The routine use of gonadotrophin-releasing hormone agonists prior to in-vitro fertilization and gamete intra-fallopian transfer: a meta-analysis of randomized controlled trials [J].Fertil Steril, 1992,58:888
  • 5Tur-Kaspa I, Confino E, Dudkiewica AB,et al. Ovarian stimulation protocol for in-vitro fertilization with gonadotropin-releasing hormone agonist widens the implantation window [J]. Fertil Steril, 1990,53:859
  • 6Smitz J, Van Den Abbeel E, et al. The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in vitro fertilization outcome in normo-ovulatory women [J]. Hum Reprod, 1992,7:1098

共引文献3

同被引文献100

引证文献9

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部